CELL THERAPY MANUFACTURING MARKET ANALYSIS

Cell Therapy Manufacturing Market, By Therapy Type (Allogeneic Cell Therapy and Autologous Cell Therapy), By Technology Type (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, 3D Technology), By Manufacturing Purpose (Clinical, Commercial, Pre-clinical), By Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025
Code : CMI1728
Pages :205
Formats :
Excel and PDF
Industry : Biotechnology

Cell Therapy Manufacturing Market Size and Trends

Global cell therapy manufacturing market is estimated to be valued at USD 5.65 Bn in 2025 and is expected to reach USD 15.14 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 15.1% from 2025 to 2032.

Cell Therapy Manufacturing Market Key Factors

To learn more about this report, Request sample copy

Increasing prevalence of chronic diseases such as cancer and cardiovascular diseases boosts demand for cell therapy products across the world. The advancements in cell therapy research and development and rise in the number of clinical trials are driving the market growth. Various market players are constantly focused on developing innovative cell therapy products, in order to expand their market share. Regulatory complexity and high costs involved can hamper the growth of the cell therapy manufacturing market.

Increasing Launch of Various Types of Technologies for Cell Therapy Manufacturing

Manufacturers are involved in developing and launching various types of technologies for cell therapy manufacturing, and this is expected to drive the growth of global cell therapy manufacturing market. For instance, in July 2022, INVETECH, a global company offering solutions, systems, and services to cell and gene therapy, announced the launch of new korus technology for autologous cell therapy production. Korus is a closed system for the production of autologous cell therapy.